VLA-4 (α4β1) engagement defines a novel activation pathway for β2 integrin-dependent leukocyte adhesion involving the urokinase receptor

Blood

Volumn 96, Issue 2, 2000, Pages 506-513

  May, Andreas E ^a   Neumann, Franz Josef ^b   Schömig, Albert ^b   Preissner, Klaus T ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; INTEGRIN; UROKINASE; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN;

ARTICLE; CELL SURFACE; CHO CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034662134     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.2.506.014k41_506_513     Document Type: Article

References (48)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115.
2. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Circulation. 1995;91:2488.
3. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301.
4. Hogg N, Berlin C. Structure and function of adhesion receptors in leukocyte trafficking, Immunol Today. 1995;16:327.
5. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068.
6. May AE, Neumann F-J, Preissner KT. The relevance of blood cell-vessel wall interactions for vascular thrombotic disease. Thromb Haemost. 1999;82:962.
7. Preissner KT, May AE, Wohn KD, Germer M, Kanse SM. Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb Haemost. 1997;78:88.
8. Petty HR, Todd RF. Integrins as promiscuous signal transduction device, Immunol Today. 1996;17: 209.
9. May AE, Kanse SM, Chavakis T, Preissner KT. Molecular interactions between the urokinase receptor and integrins in the vasculature. Fibrinol Proteol. 1998;12:205.
10. 4 integrin chains. J Immunol. 1995;154:3266.
11. McGilvray ID, Lu Z, Bitar R, Dackiw APB, Davreux CJ, Rotstein OD. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J Biol Chem. 1997;272:10287.
12. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 1995;128:1243.
13. Berlin C, Bargatze RF, Campbell JJ, et al. α4-integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 1995;80:413.
14. Gerszten RE, Lim YC, Ding HT, et al. Adhesion of monocytes to vascular cell adhesion molecule-1 -transduced human endothelial cells: implications for atherogenesis. Circ Res. 1998;82:871.
15. 1-rintegrin under flow conditions. Blood 1997;89:3837.
16. Libby P, Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest. 1993;92:538.
17. Couffinhal T, Duplaa C, Moreau C, Lamaziere D, Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res. 1994;74:225.
18. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993;92: 945.
19. Peter K, Nawroth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. ArteriosclerThromb Vasc Biol. 1997;17:505.
20. Gurbel PA, Serebruany VL. Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents. Am J Cardiol. 1998;81:772.
21. Bitsch A, Klene W, Murtada L, Prange H, Rieckmann P. A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke. 1998;29:2129.
22. Meisel SR, Shapiro H, Radnay J, et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardlal infarction: possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol. 1998;31:120.
23. Preissner KT, Wassmuth R, Müller-Bergbaus G. Physiochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J. 1985;231:349.
24. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem. 1990;265:6453.
25. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem. 1991;266:7842.
26. Andrew D, Shock A, Ball E, Ortlepp S, Bell J, Robinson M. KIM185, a monoclonal antibody to CD 18 which induces a change in the conformation of CD18 and promotes both LFA-1-and CR3-dependent adhesion. Eur J Immunol. 1993;23: 2217.
27. Wallis WJ, Hickstein DD, Schwartz BR, et al. Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils. Blood. 1986;67: 1007.
28. Diamond AS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. 1993;120:545.
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture ol human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52:2745.
30. Wei Y, Lukashev M, Simon DI, et al. Regulation of integrin function by the urokinase receptor. Science. 1996;273:1551.
31. Sitrin RG, Todd RF, Petty HR, et al. The urokinase receptor (CD87) facilitates CD11B/CD18-mediated adhesion of human monocytes. J Clin Invest. 1996;97:1942.
32. 2-integrins in vivo. J Exp Med. 1998;188:1029.
33. Smith CW, Marlin SD, Rothlein R. Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invast. 1989;83:2008.
34. Chan JR, Hyduk SJ, Cybulsky MI. Alpha 4 beta 1 integrin/VCAM-1 interaction activates αLβ2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol. 2000;164:746.
35. Kubes P, Niu X-F, Smith CW, Kehrli ME Jr, Reinhardt PH, Woodman R. A novel β1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrochalasin B or endothelial transmigration. FASEBJ. 1995;9:1103.
36. van Kooyk Y, van de Wiel-van Kemenade E, Weder P, Huijbens RJ, Figdor CG. Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium. J Exp Med. 1993;177:185.
37. 2-integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA. 1996;93:10939.
38. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol. 1997;9:714.
39. Simon DI, Rao NK, Xu H, et al. Mac-1 (CD11b/ CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood. 1996; 88:3185.
40. 2-integrins. Blood. 1999;93:2976.
41. Mizukami IF, Todd RF III. A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells. J Leukoc Biol. 1998;64:203.
42. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Prateolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 1996;15: 1572.
43. Lefer DJ, Granger DN. Monocyte rolling in early atherogenesis: vital role in lesion development. Circ Res. 1999;84:1353.
44. Ramos CL, Huo Y, Jung U. et al. Direct demonstration of P-selectin-and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237.
45. Yasukawa H, Imaizumi T, Matsuoka H, Nakashima A, Morimatsu M. Inhibition of intimai hyperplasia after ballon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function associated antigen-1. Circulation. 1997; 95:1515.
46. Rogers C, Edelman ER, Simon DI. A mAb to the β2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent impantation in rabbits. Proc Natl Acad Sci U S A. 1996;95:10134.
47. Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation. 1998;97:2511.
48. Thiagarajan, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost. 1997;78:310.